TY - JOUR AU - Lissauer, David AU - Wilson, Amie AU - Daniels, Jane AU - Middleton, Lee AU - Bishop, Jon AU - Hewitt, Catherine AU - Merriel, Abi AU - Weeks, Andrew AU - Mhango, Chisale AU - Mataya, Ronald AU - Taulo, Frank AU - Ngalawesa, Theresa AU - Chirwa, Agatha AU - Mphasa, Colleta AU - Tambala, Tayamika AU - Chiudzu, Grace AU - Mwalwanda, Caroline AU - Mboma, Agnes AU - Qureshi, Rahat AU - Ahmed, Iffat AU - Ismail, Humera AU - Gulmezoglu, Metin AU - Oladapo, Olufemi T. AU - Mbaruku, Godfrey AU - Chibwana, Jerome AU - Watts, Grace AU - Simon, Beatus AU - Ditai, James AU - Tom, Charles Otim AU - Acam, Jane-Frances AU - Ekunait, John AU - Uniza, Helen AU - Iyaku, Margaret AU - Anyango, Margaret AU - Zamora, Javier AU - Roberts, Tracy AU - Goranitis, Ilias AU - Desmond, Nicola AU - Coomarasamy, Arri PY - 2018 DA - 2018/04/23 TI - Prophylactic antibiotics to reduce pelvic infection in women having miscarriage surgery – The AIMS (Antibiotics in Miscarriage Surgery) trial: study protocol for a randomized controlled trial JO - Trials SP - 245 VL - 19 IS - 1 AB - The estimated annual global burden of miscarriage is 33 million out of 210 million pregnancies. Many women undergoing miscarriage have surgery to remove pregnancy tissues, resulting in miscarriage surgery being one of the most common operations performed in hospitals in low-income countries. Infection is a serious consequence and can result in serious illness and death. In low-income settings, the infection rate following miscarriage surgery has been reported to be high. SN - 1745-6215 UR - https://doi.org/10.1186/s13063-018-2598-3 DO - 10.1186/s13063-018-2598-3 ID - Lissauer2018 ER -